Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.36
Delayed Data
As of 12:22pm ET
 -0.03 / -2.16%
Today’s Change
0.78
Today|||52-Week Range
1.88
+37.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues43.1M42.6M34.5M31.2M
 
 
 
 
 
Cost of Goods Sold35.8M--0.00--
 
 
Depreciation And Amortization5.3M4.3M232.0K0.00
 
 
 
 
 
Operating ExpensesGross Income2.0M--34.3M--
 
 
 
General Expenses17.4M31.2M11.3M2.4M
 
 
 
 
 
Research And Development--21.0M2.7M0.00
 
 
 
Total Operating Expenses58.5M35.5M11.6M2.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.4M7.1M22.9M28.8M
 
 
 
 
 
Extraordinary Credit5.0M177.0K----
 
 
 
Extraordinary Charge-6.0M-11.5M-4.8M--
 
 
 
 
Interest Expense On Debt5.9M5.3M2.1M0.00
 
 
 
 
Other Expenses91.0K912.0K1.9M61.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.6M-6.9M18.1M28.9M
 
 
 
 
 
Income Taxes-205.0K-4.1M-28.0K-56.0K
 
 
 
 
 
Net Income-20.8M-2.8M18.2M28.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.9M46.7M43.8M44.1M
 
 
 
 
 
Shares To Calculate EPS Diluted51.9M46.7M51.0M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.06$0.38$0.65
 
 
 
 
 
EPS Diluted-$0.40-$0.06$0.36$0.65